Session Type
Meeting
Search Results for Ketoacidosis
Abstract Number: M8
SHM Converge 2022
Background: Patients with diabetes who are hospitalized with COVID-19 have been found to have increased lengths of stay and greater intensive care unit utilization compared to those without diabetes. Diabetic ketoacidosis (DKA) is an acute diabetes emergency that accounts for a high number of hospitalizations, hospital readmissions, and healthcare utilization. Our study aims to evaluate […]
Abstract Number: 121
SHM Converge 2023
Background: Diabetic Ketoacidosis (DKA) is the most common severe acute complication of diabetes, and has shown to be worsened by COVID-191. Several studies have found an association between COVID-19 and worsened outcomes from diabetic ketoacidosis (DKA).2 Vaccination against COVID-19 has led to substantial declines in the frequency, severity, and mortality from acute infection, but little […]
Abstract Number: 123
SHM Converge 2023
Background: The presence of concomitant diabetic ketoacidosis (DKA) with acute pancreatitis (AP) is not uncommon and is associated with unfavorable outcomes (1,2). However, the diagnosis of AP in DKA patients is often missed because of the overlapping clinical features. Data comparing clinical characteristics and outcomes of patients with co-existing DKA and AP with DKA alone […]
Abstract Number: 134
SHM Converge 2023
Background: Diabetic ketoacidosis (DKA) remains one of the commonest causes of medical and intensive care unit hospitalisations. DKA is a preventable hospital admission which is associated with multiple modifiable risk factors. However, little is known about factors that can predict healthcare resource utilisation in DKA. Previous studies have explored clinical and biochemical factors affecting the […]
Abstract Number: 141
SHM Converge 2021
Background: Length of stay (LOS) is an important outcome measure in the evaluation of the quality of care for hospitalized patients. LOS in adults with diabetic ketoacidosis (DKA) is reported to be about 3 days, but detailed information about LOS in pediatric patients with DKA is lacking. Knowledge of factors that impact LOS is essential […]
Abstract Number: 152
SHM Converge 2023
Background: Diabetes mellitus (DM) is a chronic disease where treatment is directed toward reducing and delaying its potentially severe short- and long-term complications. The estimated population (20-79 years old) with diabetes is 32.22 million in the United States, and 12.5% of people live with undiagnosed diabetes (Figure 1). Diabetes Mellitus is currently the most prevalent […]
Abstract Number: 159
SHM Converge 2021
Background: COVID-19 has placed an unprecedented strain on healthcare systems worldwide, increasing demand for critical care beds1. To address shortage of critical care beds, innovative methods to increase capacity are needed. At our large, urban academic safety-net hospital, patients with diabetic ketoacidosis (DKA) are admitted to critical care units for intravenous (IV) insulin administration and […]
Abstract Number: 252
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: At our urban, academic hospital, use of outdated protocols and unnecessary variations in the care of DKA patients treated with ICU requiring IV insulin protocols have led to multiple safety events, delays in care with associated increased costs, and overtreatment of hyperglycemia with ketosis frequently resulting in unnecessary ICU utilization. After multi-disciplinary stakeholder development […]
Abstract Number: 290
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Background: Diabetic ketoacidosis (DKA) is a serious, acute complication of diabetes mellitus caused by a state of insulin deficiency requiring exogenous insulin administration. Significant variation in intensive care unit (ICU) admission rates for DKA exists among hospitals, due to patient- and institution-specific factors, with rates ranging from 16-81%. Patients with DKA admitted to an ICU […]
Abstract Number: 378
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Case Presentation: A 40-year-old previously healthy female presented nine weeks postpartum with numerous episodes of nonbilious, nonbloody emesis that began 24 hours prior to admission. She took no medications and denied fevers, chills, dysuria, cough, or ingestion of alcohol or other substances. She reported that since her uncomplicated vaginal birth, she had been adhering to […]